LYEL
LYEL
NASDAQ · Biotechnology

Lyell Immunopharma Inc

$11.01
+0.21 (+1.94%)
As of Sep 20, 10:26 PM ET ·
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Buy 12 86%
Hold 1 7%
Sell 1 7%
Price Target
Analyst Price Target +153.9% upside
Low Target $18.45
Average Target $27.95
High Target $35.39
Current Price $11.01
Current
$11.01
Target
$27.95
$18.45 $27.95 avg $35.39
Scenario Analysis
Bear Case
$18.45
67.6%
Low target
Base Case
$27.95
+153.9%
Avg target
Bull Case
$35.39
+221.4%
High target
Risk/Reward
3.3x
Highly favorable
Price in Context
52-Week High
$45.00
-75.5% from high
52-Week Low
$10.46
+5.3% from low
Target vs 52W High
$27.95
-37.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.8%
AMGN
Amgen Inc
Hold 43 47% $190.87 -53.0%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +141.2%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -14.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
Hold 30 37% $149.45 -18.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -63.8%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -40.3%